The stock is meeting Daryl Guppy’s multiple moving averages set-up rules as it is trading above both the short and long-term moving averages. Talking about the indicators, the 14-period RSI on the daily timeframe has marked a fresh 14-period high and is trading above its previous swing high.

Net interest income (NII) came in at Rs 9,279.75 crore, which witnessed a growth of 19.9 per cent YoY, compared to Rs 7,737.43 crore in Q1FY20. 

Reserve Bank of India (RBI) conducted a stress test suggesting that the COVID-19 pandemic could lead Indian banks’ gross NPA to its two-decade high. Read on to find out more.

Here is a list of mutual funds that are in line to be launched.

The consolidated net sales reported in Q1FY21 came in at Rs 5,940.92 crore, which declined by 53.31 per cent YoY from Rs 12,723.86 crore in Q1FY20. 

On Friday, the stock has given a breakdown of the upward sloping trendline of the rising channel, which suggests a correction before another northward journey. This breakdown is confirmed by a relatively higher volume.

Domestic benchmark indices closed flat on Friday as Sensex dropped by 0.03 per cent or 11.57 points to settle at 38,128.90 while Nifty fell by 0.19 per cent or 21.30 points to end at 11,194.15.

The stock of Deepak Nitrite Limited has given a cup & handle pattern breakout on the daily timeframe. This breakout is supported by robust volumes. The length of the cup with handle pattern was of 54 trading sessions and the depth of the pattern was 19 per cent. 

Pharma-major, Lupin Limited, announced that it has received tentative approval for its Empagliflozin and Linagliptin tablet in the strengths of 10 mg/5 mg and 25 mg/5 mg from United States Food and Drug Administration (USFDA), to commercialise a generic version of Glyxambi tablets, of Boehringer Ingelheim Pharmaceuticals, Inc.

State-owned Bank of Maharashtra share prices was trading in the green on Friday, climbing by more than 4 per cent after the bank reported positive June quarter earnings on the back of a decline in bad loans.